Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Barratt

Showing results (101-110 of 272) with videos related to

Pageof 28
Sort By:
Kidney International Reports|December 12, 2022
One-Year estimated GFR Slope Independently Predicts Clinical Benefit in Immunoglobulin A NephropathyRichard A Lafayette, Heather N Reich, Andrew M Stone, et al.
Clinical Kidney Journal|April 16, 2025
eGFR slope modelling predicts long-term clinical benefit with nefecon in a real-world IgAN populationJonathan Barratt, Andrew M Stone, Heather N Reich, et al.
Future Healthcare Journal|May 29, 2024
Core needs and diverse opportunity: A survey of academic clinical lecturers and the effects of the COVID-19 pandemicAnna Sadnicka, Anthony Howard, Rama Hakim, et al.
International Journal of Immunogenetics|August 28, 2025
A Prospective Pilot Study to Investigate Whether Donor-Derived Cell-Free DNA Can Be Used as a Biomarker of Recurrent IgA Nephropathy Post-Kidney TransplantationJudith Owusuwaah Asiedu-Basoah, Stephen Weston, Jonathan Barratt, et al.
Kidney International|February 10, 2012
An update on the pathogenesis and treatment of IgA nephropathyJoanna K Boyd, Chee K Cheung, Karen Molyneux, et al.
Journal of Autoimmunity|August 13, 2019
Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneysScott Taylor, Kyriaki Pieri, Paolo Nanni, et al.
Kidney International Reports|May 20, 2021
Identifying Information Needs of Patients With IgA Nephropathy Using an Innovative Social Media-stepped Analytical ApproachCristina Vasilica, Tom Oates, Christian Clausner, et al.
Frontiers in Nephrology|February 16, 2024
The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapiesChee Kay Cheung, Jonathan Barratt, Adrian Liew, et al.
Indian Journal of Nephrology|August 19, 2024
IgA Nephropathy: Emerging Mechanisms of DiseaseLydia E Roberts, Chloe E C Williams, Louise Oni, et al.
Research Involvement and Engagement|August 23, 2025
The importance of patient engagement when promoting age-inclusive researchLydia E Roberts, James O Burton, Manish D Sinha, et al.
Pageof 28

Showing results (101-110 of 272) with videos related to

Sort By:
Pageof 28
Kidney International Reports|December 12, 2022
One-Year estimated GFR Slope Independently Predicts Clinical Benefit in Immunoglobulin A NephropathyRichard A Lafayette, Heather N Reich, Andrew M Stone, et al.
Clinical Kidney Journal|April 16, 2025
eGFR slope modelling predicts long-term clinical benefit with nefecon in a real-world IgAN populationJonathan Barratt, Andrew M Stone, Heather N Reich, et al.
Future Healthcare Journal|May 29, 2024
Core needs and diverse opportunity: A survey of academic clinical lecturers and the effects of the COVID-19 pandemicAnna Sadnicka, Anthony Howard, Rama Hakim, et al.
International Journal of Immunogenetics|August 28, 2025
A Prospective Pilot Study to Investigate Whether Donor-Derived Cell-Free DNA Can Be Used as a Biomarker of Recurrent IgA Nephropathy Post-Kidney TransplantationJudith Owusuwaah Asiedu-Basoah, Stephen Weston, Jonathan Barratt, et al.
Kidney International|February 10, 2012
An update on the pathogenesis and treatment of IgA nephropathyJoanna K Boyd, Chee K Cheung, Karen Molyneux, et al.
Journal of Autoimmunity|August 13, 2019
Phosphatidylethanolamine binding protein-4 (PEBP4) is increased in IgA nephropathy and is associated with IgA-positive B-cells in affected kidneysScott Taylor, Kyriaki Pieri, Paolo Nanni, et al.
Kidney International Reports|May 20, 2021
Identifying Information Needs of Patients With IgA Nephropathy Using an Innovative Social Media-stepped Analytical ApproachCristina Vasilica, Tom Oates, Christian Clausner, et al.
Frontiers in Nephrology|February 16, 2024
The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapiesChee Kay Cheung, Jonathan Barratt, Adrian Liew, et al.
Indian Journal of Nephrology|August 19, 2024
IgA Nephropathy: Emerging Mechanisms of DiseaseLydia E Roberts, Chloe E C Williams, Louise Oni, et al.
Research Involvement and Engagement|August 23, 2025
The importance of patient engagement when promoting age-inclusive researchLydia E Roberts, James O Burton, Manish D Sinha, et al.
Pageof 28